Published 2020 | Version v1
Publication

Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study

Citation

An error occurred while generating the citation.

Description

People living with human immunodeficiency virus (PLHIV) are at increased risk of atherosclerotic cardiovascular disease (ASCVD) and are prone to statin-related adverse events from drug-drug interactions with certain antiretroviral regimens.

Additional details

Created:
April 14, 2023
Modified:
November 28, 2023